Academic Detailing to Advance Naloxone Prescribing in Rural Primary Care: A 2-Year Pilot Study
Journal of Primary Care & Community Health · 2025
DOI: 10.1177/21501319251391284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Leah Tobey-Moore und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Arkansas for Medical Sciences, Little Rock, USA. Hauptthemen laut MEDLINE: Naloxone, Narcotic Antagonists, Primary Health Care, Practice Patterns, Physicians'. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Opioid-related overdoses remain a critical concern in Arkansas, where Primary Care Providers (PCPs) play a key role in overdose prevention through naloxone education and prescribing. Academic Detailing (AD) is a promising strategy to improve provider knowledge, confidence, and adoption of naloxone-related practices, yet feasibility in rural primary care remains underexplored.
Aim
To evaluate the feasibility and impact of a brief, continuing education (CE)-accredited AD intervention on naloxone prescribing confidence and behavior among rural PCPs over 2 years. Methodology: The University of Arkansas for Medical Sciences (UAMS) delivered a 30-minute virtual AD session, “Preventing Opioid Overdose with Naloxone,” to 15 PCPs within a large Federally Qualified Health Center network. A matched control group of 15 PCPs was included. Implementation service outcomes (via prescribing) were assessed using repeated measures multivariate analysis of variance (MANOVA). Immediate post-session and 2-year follow-up surveys examined confidence, practice changes, and implementation experiences.
Results
Naloxone prescribing increased in both groups; however, there was no significant group-by-time interaction. All post-session respondents reported increased confidence. At 2 years, 92% indicated the AD session continued to influence their practice. Qualitative feedback identified barriers (stigma, cost, and limited patient update) and facilitators (peer support and institutional policies) shaping prescribing.
Conclusion
This pilot demonstrates the feasibility of delivering AD in rural primary care and provides evidence of early penetration within an FQHC network. While prescribing increases could not be attributed solely to the intervention, AD was associated with sustained improvements in provider knowledge, confidence, and perceived relevance of naloxone prescribing. These findings highlight the limitations of brief educational sessions when implemented without complementary system-level supports, underscoring the need for multilevel approaches to expand naloxone access in underserved communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Arkansas for Medical Sciences, Little Rock, USA.
- ARcare Federally Qualified Healthcare Center, Augusta, USA.
ORCID-Profile: Leah Tobey-Moore, Stacie Massey
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Tobey-Moore, L., Breckling, M. N., Ali, M., Karr, M., Massey, S., & Hudson, T. J. (2025). Academic Detailing to Advance Naloxone Prescribing in Rural Primary Care: A 2-Year Pilot Study. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251391284
Vancouver
Tobey-Moore L, Breckling MN, Ali M, Karr M, Massey S, Hudson TJ. Academic Detailing to Advance Naloxone Prescribing in Rural Primary Care: A 2-Year Pilot Study. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251391284
BibTeX
@article{TobeyMoore2025,
author = {Tobey-Moore, Leah and Breckling, Meghan N and Ali, Mohab and Karr, Misha and Massey, Stacie and Hudson, Teresa J},
title = {Academic Detailing to Advance Naloxone Prescribing in Rural Primary Care: A 2-Year Pilot Study},
journal = {Journal of Primary Care & Community Health},
year = {2025},
doi = {10.1177/21501319251391284}
}
EUVIMED